Eli Lilly (LLY)

$770. 1.12 (0.15%)

19:00 EDT LLY Stock Quote Delayed 30 Minutes

3 Nasdaq Stocks to Sell in September Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor Sep 7, 2023

These Nasdaq stocks to sell are all risky plays with uncertain futures. It's a good idea to sell or trim your positions in them now.

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

7 A-Rated Blue-Chip Stocks to Secure Your Financial Future

7 Stocks Sitting At 52-Week Highs Right Now

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 1.67M

Day's Range $767.10 - $774.87

52-Week Range $434.34 - $800.78

Dividend & Yield $4.52 (0.59%)

LLY Stock Predictions, Articles, and Eli Lilly News

From InvestorPlace
From the Web

3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of

By Larry Ramer, InvestorPlace Contributor Aug 30, 2023

Worries about biotech stocks are way overdone, so the sector should make a big comeback in the coming months.

The 3 Most Promising Pharma Stocks to Own Now

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Aug 30, 2023

A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride.

The 3 Blue-Chip Stocks Every Investor Needs to Own Today

By Rick Orford, InvestorPlace Contributor Aug 28, 2023

These three blue-chip stocks are all industry giants in their respective sectors — and offer future growth and stability.

Want to Get Rich? 3 Game-Changing Growth Stocks to Buy Right Now

By Joel Baglole, InvestorPlace Contributor Aug 28, 2023

Look to these growth stocks to buy to provide huge growth moving forward as they each have strong catalysts and bullish long-term outlooks.

7 A-Rated Growth Stocks to Grab Up Now

By Louis Navellier and the InvestorPlace Research Staff Aug 24, 2023

Investing in A-rated growth stocks is one of the best tools you have to build your portfolio and set it up for long-time growth.

7 A-Rated Biotech Stocks for Your August Buy List

By Louis Navellier and the InvestorPlace Research Staff Aug 17, 2023

Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.

3 Growth Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 9, 2023

Stock markets are enduring turmoil this August. Since the beginning of the month, the benchmark S&P 500 index has declined 2%. The downturn comes amid…

Eli Lilly (LLY) Stock Just Reached a New All-Time High

By Josh Enomoto, InvestorPlace Contributor Aug 8, 2023

Pharma giant Eli Lilly saw LLY stock reach record heights as the company posted strong Q2 results, undergirded by a key diabetes drug.

7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes

By Joel Baglole, InvestorPlace Contributor Jul 27, 2023

Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each year, which works out to nearly $13,000 per person.

3 Risky Stocks to Avoid at All Costs in 2023

By Omor Ibne Ehsan Jul 26, 2023

These are the top stocks to avoid before the stock market rally starts to lose momentum and plateau this year.

LLY Stock Alert: What to Know as Eli Lilly Acquires Versanis Bio

By William White, InvestorPlace Writer Jul 14, 2023

Eli Lilly (LLY) stock is a hot topic among traders on Friday after the company announced its acquisition of Versanis Bio.

The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023

By Joel Baglole, InvestorPlace Contributor Jun 30, 2023

Investors looking to buy low and eventually sell high would be smart to take a position with one or more of these pharma stocks.

3 Dividend Stocks That Have Insiders Running for the Exit

By Chris Markoch, InvestorPlace Contributor Jun 30, 2023

One measurement used to find dividend stocks to avoid is the level of insider selling; here are three stocks that fit that description

Why Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?

By William White, InvestorPlace Writer Jun 29, 2023

Sigilon Therapeutics (SGTX) stock is rocketing higher on Thursday morning after Eli Lilly (LLY) agrees to acquire the company.

Why Is Dice Therapeutics (DICE) Stock Up 38% Today?

By William White, InvestorPlace Writer Jun 20, 2023

Dice Therapeutics (DICE) stock is surging higher on Tuesday after Eli Lilly (LLY) announced plans to acquire the biopharmaceutical company.

7 Growth Stocks to Sell in June Before They Crash and Burn

By Thomas Niel, InvestorPlace Contributor Jun 5, 2023

Taking a look at scores of names trading at premium valuations due to high growth expectations, I have found seven that stand out as growth stocks to sell. Many of them may only be at risk of a moderate correction, but some of them could experience more serious price declines.

Eli Lilly (LLY)

3 Nasdaq Stocks to Sell in September Before They Crash & Burn

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

7 A-Rated Blue-Chip Stocks to Secure Your Financial Future

7 Stocks Sitting At 52-Week Highs Right Now

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Eli Lilly (LLY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

LLY Stock Predictions, Articles, and Eli Lilly News

Subscriber Sign in